TNFSF10 and diabetes mellitus: Studies modeling diabetes have indicated that TRAIL deficiency and blockade increase the incidence of Type-I diabetes, lead to beta cell dysfunction, affect glucose tolerance, and cause hyperinsulinemia [10, 12].